{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:04:16Z","timestamp":1789956256415,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"vor","delay-in-days":385,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH","doi-asserted-by":"publisher","award":["U01-NS066912"],"award-info":[{"award-number":["U01-NS066912"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH","doi-asserted-by":"publisher","award":["R01NS04528"],"award-info":[{"award-number":["R01NS04528"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH","doi-asserted-by":"publisher","award":["NS078370"],"award-info":[{"award-number":["NS078370"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH","doi-asserted-by":"publisher","award":["NS080514"],"award-info":[{"award-number":["NS080514"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"crossref","award":["GM080356"],"award-info":[{"award-number":["GM080356"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J007498\/1"],"award-info":[{"award-number":["BB\/J007498\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L01923X\/1"],"award-info":[{"award-number":["BB\/L01923X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"crossref","award":["14834"],"award-info":[{"award-number":["14834"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C20953\/A18644"],"award-info":[{"award-number":["C20953\/A18644"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Optical Biology Shared Resource of the Cancer Center","award":["CA-62203"],"award-info":[{"award-number":["CA-62203"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.chembiol.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T01:26:45Z","timestamp":1468632405000},"page":"849-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models"],"prefix":"10.1016","volume":"23","author":[{"given":"Luisa","family":"Quinti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Moniot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa\u00a0F.","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0J.","family":"Van\u00a0Kanegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda\u00a0S.","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Pallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan\u00a0G.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharadha\u00a0Dayalan","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Runne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazifa\u00a0Abdul","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Leyfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele\u00a0M.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddine","family":"Saiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John\u00a0E.","family":"Landers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Luthi-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Abagyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albena\u00a0T.","family":"Dinkova-Kostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Steegborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u00a0Lawrence","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald\u00a0C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie\u00a0M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey\u00a0G.","family":"Kazantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2016.05.015_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2016.05.015_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.neuro.2007.07.010","article-title":"Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease","volume":"28","author":"Aguilera","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.chembiol.2016.05.015_bib3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.chembiol.2016.05.015_bib4","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","article-title":"The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models","volume":"2","author":"Chopra","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2016.05.015_bib5","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1093\/nar\/gks409","article-title":"Identification of novel NRF2-regulated genes by ChIP-seq: influence on retinoid X receptor alpha","volume":"40","author":"Chorley","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2016.05.015_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/hmg\/ddq055","article-title":"CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease","volume":"19","author":"Crittenden","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2016.05.015_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2016.05.015_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.2000.7551","article-title":"ST14A cells have properties of a medium-size spiny neuron","volume":"167","author":"Ehrlich","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.chembiol.2016.05.015_bib9","doi-asserted-by":"crossref","first-page":"e16172","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2016.05.015_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.chembiol.2016.05.015_bib11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Innamorato","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2016.05.015_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1196\/annals.1427.036","article-title":"The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration","volume":"1147","author":"Johnson","year":"2008","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.chembiol.2016.05.015_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington's disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2016.05.015_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157488912803252023","article-title":"The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases","volume":"7","author":"Joshi","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.chembiol.2016.05.015_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1087057110373392","article-title":"Composite primary neuronal high-content screening assay for Huntington's disease incorporating non-cell-autonomous interactions","volume":"15","author":"Kaltenbach","year":"2010","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.chembiol.2016.05.015_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2011.01.004","article-title":"Transcription factor Nrf2 suppresses LPS-induced hyperactivation of BV-2 microglial cells","volume":"233","author":"Koh","year":"2011","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.chembiol.2016.05.015_bib17","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1523\/JNEUROSCI.5865-09.2010","article-title":"Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease","volume":"30","author":"Li","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.chembiol.2016.05.015_bib18","doi-asserted-by":"crossref","first-page":"32307","DOI":"10.1074\/jbc.C112.403048","article-title":"Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein","volume":"287","author":"Liu","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2016.05.015_bib19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2016.05.015_bib20","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2016.05.015_bib21","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1093\/hmg\/ddg271","article-title":"Fly models of Huntington's disease","volume":"12 Spec No 2","author":"Marsh","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2016.05.015_bib22","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1093\/hmg\/ddr326","article-title":"The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS","volume":"20","author":"Maxwell","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2016.05.015_bib23","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals","volume":"107","author":"McMahon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2016.05.015_bib24","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2016.05.015_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1006\/bbrc.1999.1109","article-title":"Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element","volume":"261","author":"Moinova","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2016.05.015_bib26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"Moller","year":"2010","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.chembiol.2016.05.015_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jsb.2013.02.012","article-title":"Crystal structure analysis of human Sirt2 and its ADP-ribose complex","volume":"182","author":"Moniot","year":"2013","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.chembiol.2016.05.015_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase","volume":"11","author":"North","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2016.05.015_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2016.05.015_bib30","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1038\/emboj.2013.200","article-title":"The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation","volume":"32","author":"Pais","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2016.05.015_bib31","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2016.05.015_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1124\/dmd.113.051904","article-title":"Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice","volume":"41","author":"Pratt-Hyatt","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chembiol.2016.05.015_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.chembiol.2016.05.015_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1172","article-title":"Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6\/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model","volume":"2","author":"Quinti","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.chembiol.2016.05.015_bib35","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/ncomms3327","article-title":"An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms","volume":"4","author":"Rauh","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2016.05.015_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2011.03.017","article-title":"Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay","volume":"43","author":"Reinhart","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.chembiol.2016.05.015_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/biof.1013","article-title":"Protein oxidation in Huntington disease","volume":"38","author":"Sorolla","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.chembiol.2016.05.015_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.chembiol.2016.05.015_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2016.05.015_bib40","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1007\/s00018-008-8357-y","article-title":"Biological and potential therapeutic roles of sirtuin deacetylases","volume":"65","author":"Taylor","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.chembiol.2016.05.015_bib41","doi-asserted-by":"crossref","first-page":"142ra197","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chembiol.2016.05.015_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nchembio.1308","article-title":"Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration","volume":"9","author":"Tsvetkov","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2016.05.015_bib43","first-page":"314082","article-title":"The Nrf2\/are pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.chembiol.2016.05.015_bib44","first-page":"267","article-title":"The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders","volume":"4","author":"van Muiswinkel","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.chembiol.2016.05.015_bib45","doi-asserted-by":"crossref","first-page":"14525","DOI":"10.1073\/pnas.0704482104","article-title":"Inhibitors of metabolism rescue cell death in Huntington's disease models","volume":"104","author":"Varma","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2016.05.015_bib46","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/0008-5472.CAN-12-3386","article-title":"RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2","volume":"73","author":"Wang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2016.05.015_bib47","doi-asserted-by":"crossref","first-page":"e39006","DOI":"10.1371\/journal.pone.0039006","article-title":"Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2016.05.015_bib48","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI79735","article-title":"NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage","volume":"125","author":"Xiong","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2016.05.015_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2012.09.012","article-title":"Deficiency in the nuclear factor E2-related factor 2 renders pancreatic beta-cells vulnerable to arsenic-induced cell damage","volume":"264","author":"Yang","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.chembiol.2016.05.015_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/toxsci\/kfp115","article-title":"Introducing the \u201cTCDD-inducible AhR-Nrf2 gene battery\u201d","volume":"111","author":"Yeager","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chembiol.2016.05.015_bib51","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1073\/pnas.89.6.2399","article-title":"A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure","volume":"89","author":"Zhang","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945616301957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945616301957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:23:36Z","timestamp":1536575016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945616301957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2451945616301957"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2016.05.015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726615992.793538957","asserted-by":"object"}]},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}